PRESS RELEASE : Comprehensive PCR COVID-19 testing ensures safer return to school after summer holidays

DGAP-News: SYNLAB AG / Key word(s): Product Launch 
Comprehensive PCR COVID-19 testing ensures safer return to school after summer holidays 
2021-07-12 / 10:40 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
SYNLAB AG 
Moosacher Straße 88 
80809 Munich 
Germany 
Comprehensive PCR COVID-19 testing ensures safer return to school after summer holidays 
  . Safe and successful return to classroom teaching after the summer holidays will be paramount for the education and 
    social well-being of school children 
  . Early and accurate detection of infections helps to protect unvaccinated school children and to reduce the spread 
    of COVID-19 
  . The very high sensitivity of PCR tests allows early detection and reduces the risk of false-positive or 
    false-negative results 
  . SYNLAB has broad experience with implementing comprehensive and systematic PCR-based testing programmes in various 
    European countries 
  . Innovative solutions can offer easier sampling with so-called lollipop tests and more efficient and cost-effective 
    PCR tests by pooling samples 
SYNLAB, Europe's leading medical diagnostic services provider, recommends the general use of comprehensive PCR testing 
programmes in primary schools and preschools. To protect unvaccinated children whose education and social-wellbeing 
benefits from classroom teaching. With the spread of the delta variant of COVID-19 and the absence of approved vaccines 
for children under 12 years of age, reliable testing methods are an important cornerstone to ensure a safe and 
successful return to classroom teaching after the summer holidays. 
SYNLAB has broad experience with implementing comprehensive and systematic PCR testing programmes in schools. Depending 
on the prevailing regulations and conditions, various PCR sampling, testing, and reporting methods can be used. SYNLAB 
has been able to contribute to safe school operations in France, Germany, Portugal, Switzerland, and many other 
European countries. SYNLAB has created innovative solutions to allow easier sampling via so-called lollipop tests as 
well as more efficient test methods by pooling samples for PCR testing. 
Lollipop PCR tests are particularly well suited for use in primary schools and preschools due to the simple and safe 
sampling, which can be carried out in a few minutes for an entire group. This saves valuable classroom time in 
comparison to the rapid antigen testing procedure. The children only have to suck on a cotton swab for about 30 
seconds, which is much more pleasant and faster than the conventional sampling procedure. For hassle-free sampling, 
SYNLAB-supported schools, their teachers and parents are guided step-by-step through the process by a largely 
self-explanatory smartphone app (SYNLAB Access). The test results are also transmitted directly via the app. 
The pooling of samples makes the high-sensitivity PCR testing more efficient and cost-effective. The risk of 
false-positive or false-negative tests is significantly reduced in comparison to rapid antigen tests. At the same time, 
infections can be detected at an early stage which reduces the number of transmissions by infected children. Pools of 
up to 25 samples are analysed on the same day and the test results are available the next morning at the latest. In 
case of a positive pool test result, all children participating in the pool are tested individually with an additional 
PCR test. Longer quarantine measures or domestic isolation would only apply to the positively tested children. The 
advantages of high-sensitivity PCR testing outweigh the disadvantage of longer processing time compared to rapid 
antigen tests. 
In several regions, schools are already using the combination of simple and safe lollipop sampling and efficient pooled 
PCR processing. Since May 2021, SYNLAB is part of a consortium of medical diagnostic service providers that tests all 
primary school children in North Rhine-Westphalia, Germany's federal state with the most inhabitants. After a short 
familiarisation phase, the feedback from teachers, nursery teachers and parents is very positive. Especially the time 
saved during lessons at school as well as the child-friendly sampling compared to other test methods are seen as great 
advantages. 
Mathieu Floreani, CEO of SYNLAB, underlines the added value of lollipop PCR tests: "Many countries return to normal 
classroom teaching thanks to low infection numbers. This is great news. Now we must focus on safe and simple testing 
concepts in order to sustain school operations after the summer holidays for the longer term. The pooled lollipop PCR 
tests represent a great example for innovation and our medical excellence. The ease of sample collection is a real 
advantage, especially with the younger children. In addition, the PCR pooling method allows us to analyse the large 
amount of samples efficiently and cost-effectively while maintaining a high level of accuracy. In Germany, we have 
already shown that we can set up a comprehensive infrastructure for lollipop PCR testing within a few weeks. With this 
innovative and child-friendly test method, we make an important contribution to reducing the spread of the virus and 
safeguarding normal classroom teaching in schools." 
 
For more information: 
Media contact:                        [phone] 
Florian Brueckner, FTI Consulting     [e-mail] 
Investor contact:                     [phone] 
Mark Reinhard, SYNLAB                 [e-mail] About SYNLAB   . SYNLAB, (ISIN: DE000A2TSL71, SYMBOL: SYAB) is the largest European clinical laboratory and medical diagnostic 

services company and offers a full range of innovative and reliable medical diagnostics for patients, practising

doctors, clinics and the pharmaceutical industry. . Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in

human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of

patients and customers. . SYNLAB operates in 36 countries across four continents and holds leading positions in most markets. Around 20,000

employees, including over 1,200 medical experts, as well as a large number of other specialists such as biologists,

chemists and laboratory technicians, contribute every day to the Group's worldwide success. SYNLAB carries out 500

million laboratory tests per year and achieved revenues of EUR 2.6 billion in 2020. . More information can be found on www.synlab.com -----------------------------------------------------------------------------------------------------------------------

2021-07-12 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      SYNLAB AG 
              Moosacher Straße 88 
              80809 Munich 
              Germany 
Phone:        [phone] 
E-mail:       [e-mail] 
Internet:     www.synlab.com/ 
ISIN:         DE000A2TSL71 
WKN:          A2TSL7 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1217514 
 
End of News   DGAP News Service 
=------------ 

1217514 2021-07-12

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1217514&application_name=news

(END) Dow Jones Newswires

July 12, 2021 04:41 ET (08:41 GMT)